BioSpace News Archive

We are pleased to announce that Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI and the EMA as a Class C CDx assay, meeting the stringent new IVDR 2017/746) requirements.

Revvity, Inc . (NYSE: PKI), today reported financial results for the first quarter ended April 2, 2023.

Praxis Precision Medicines, Inc. announced positive topline results from the PRAX-628 Phase 1 healthy volunteer study evaluating the safety, tolerability and pharmacokinetics of single ascending doses and multiple ascending doses of PRAX-628.

PepGen Inc. reported financial results for the first quarter ended March 31, 2023.

Nusano, Inc. announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains.

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported financial results and business highlights for the first quarter of 2023.

First Wave BioPharma, Inc. announced that it has completed patient screening in its ongoing Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

Pyxis Oncology, Inc., a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported financial results for the quarter ended March 31, 2023, and provided a corporate update.

The Insight Partners published latest research report on “Male Infertility Market Size Report, Share, Trends, Growth & Key Companies Forecast to 2027 - COVID-19 Impact and Global Analysis by Test; Treatment Type; Distribution Channel

2seventy bio, Inc. (Nasdaq: TSVT) today announced the presentation of four abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place from June 2-6, 2023 in Chicago, Illinois and six abstracts at the European Hematology Association (EHA) Congress, taking place in Frankfurt, Germany from June 8-11, 2023.